{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:09:45Z","timestamp":1779304185408,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00415-023-11595-4","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T15:02:25Z","timestamp":1677942145000},"page":"2659-2673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["CAR t-cell therapy in BOlogNa\u2013NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON\u2013NEUTRAL): proposed protocol and results from an Italian study"],"prefix":"10.1007","volume":"270","author":[{"given":"Umberto","family":"Pensato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Amore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Muccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Sammali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Rondelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Nicodemo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Mondini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Sambati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Maria","family":"Asioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Cretella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susy","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Spinardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Faccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Paccagnella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Pierucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Casadei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Bonaf\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Cortelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8894-2187","authenticated-orcid":false,"given":"Maria","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"key":"11595_CR1","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/S1470-2045(19)30823-X","volume":"21","author":"AK Singh","year":"2020","unstructured":"Singh AK, McGuirk JP (2020) CAR T cells: continuation in a revolution of immunotherapy. Lancet Oncol 21:e168\u2013e178","journal-title":"Lancet Oncol"},{"key":"11595_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL et al (2019) ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant 25:625\u2013638","journal-title":"Biol Blood Marrow Transplant"},{"key":"11595_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.577027","volume":"11","author":"J Gust","year":"2020","unstructured":"Gust J, Ponce R, Liles WC, Garden GA, Turtle CJ (2020) Cytokines in CAR T cell-associated neurotoxicity. Front Immunol 11:577027","journal-title":"Front Immunol"},{"key":"11595_CR4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.25502","volume":"86","author":"J Gust","year":"2019","unstructured":"Gust J, Finney OC, Li D et al (2019) Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapy. Ann Neurol 86:42\u201354","journal-title":"Ann Neurol"},{"key":"11595_CR5","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1158\/2159-8290.CD-17-1319","volume":"8","author":"BD Santomasso","year":"2018","unstructured":"Santomasso BD, Park JH, Salloum D et al (2018) Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia. Cancer Discov 8:958\u2013971","journal-title":"Cancer Discov"},{"key":"11595_CR6","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/brain\/awz053","volume":"142","author":"DB Rubin","year":"2019","unstructured":"Rubin DB, Danish HH, Ali AB et al (2019) Neurological toxicities associated with chimeric antigen receptor T-cell therapy. Brain 142:1334\u20131348","journal-title":"Brain"},{"key":"11595_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00415-021-10766-5","volume":"269","author":"U Pensato","year":"2021","unstructured":"Pensato U, Amore G, D\u2019Angelo R et al (2021) Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity. J Neurol 269:609\u2013615","journal-title":"J Neurol"},{"key":"11595_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.936141","volume":"13","author":"U Pensato","year":"2022","unstructured":"Pensato U, Guarino M, Muccioli L (2022) The role of neurologists in the era of cancer immunotherapy: focus on CAR T-cell therapy and immune checkpoint inhibitors. Front Neurol 13:936141","journal-title":"Front Neurol"},{"key":"11595_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/jnen\/nly064","volume":"77","author":"M Torre","year":"2018","unstructured":"Torre M, Solomon IH, Sutherland CL et al (2018) Neuropathology of a case with fatal CAR T-cell-associated cerebral edema. J Neuropathol Exp Neurol 77:877\u2013882","journal-title":"J Neuropathol Exp Neurol"},{"key":"11595_CR10","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1007\/s00415-022-11117-8","volume":"269","author":"U Pensato","year":"2022","unstructured":"Pensato U, Muccioli L, Zinzani P et al (2022) Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review. J Neurol 269:4560\u20134563","journal-title":"J Neurol"},{"key":"11595_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001511","volume":"8","author":"MV Maus","year":"2020","unstructured":"Maus MV, Alexander S, Bishop MR et al (2020) Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events. J Immunother Cancer 8:e001511","journal-title":"J Immunother Cancer"},{"key":"11595_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","volume":"15","author":"SS Neelapu","year":"2018","unstructured":"Neelapu SS, Tummala S, Kebriaei P et al (2018) Chimeric antigen receptor T-cell therapy\u2014assessment and management of toxicities. Nat Rev Clin Oncol 15:47\u201362","journal-title":"Nat Rev Clin Oncol"},{"key":"11595_CR13","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1182\/blood.2020008865","volume":"137","author":"P Strati","year":"2021","unstructured":"Strati P, Ahmed S, Furqan F et al (2021) Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma. Blood 137:3272\u20133276","journal-title":"Blood"},{"key":"11595_CR14","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","volume":"7","author":"J Gust","year":"2017","unstructured":"Gust J, Hay KA, Hanafi LA et al (2017) Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells. Cancer Discov 7:1404\u20131419","journal-title":"Cancer Discov"},{"key":"11595_CR15","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1182\/bloodadvances.2020002228","volume":"4","author":"P Strati","year":"2020","unstructured":"Strati P, Nastoupil LJ, Westin J et al (2020) Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv 4:3943\u20133951","journal-title":"Blood Adv"},{"key":"11595_CR16","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1001\/jamaneurol.2020.2703","volume":"77","author":"DB Rubin","year":"2020","unstructured":"Rubin DB, Al Jarrah A, Li K et al (2020) Clinical predictors of neurotoxicity after chimeric antigen receptor T-Cell therapy. JAMA Neurol 77:1536","journal-title":"JAMA Neurol"},{"key":"11595_CR17","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/neuonc\/noab077","volume":"23","author":"D Maillet","year":"2021","unstructured":"Maillet D, Belin C, Moroni C et al (2021) Evaluation of mid-term (6\u201312 months) neurotoxicity in B-cell lymphoma patients treated with CAR T cells: a prospective cohort study. Neuro Oncol 23:1569\u20131575","journal-title":"Neuro Oncol"},{"key":"11595_CR18","doi-asserted-by":"publisher","first-page":"E427","DOI":"10.1002\/ajh.26330","volume":"96","author":"K Wudhikarn","year":"2021","unstructured":"Wudhikarn K, Bansal R, Khurana A et al (2021) Age defining immune effector cell associated neurotoxicity syndromes in aggressive large B cell lymphoma patients treated with axicabtagene ciloleucel. Am J Hematol 96:E427\u2013E430","journal-title":"Am J Hematol"},{"key":"11595_CR19","doi-asserted-by":"publisher","first-page":"18997","DOI":"10.1038\/s41598-020-76055-9","volume":"10","author":"C Belin","year":"2020","unstructured":"Belin C, Devic P, Ayrignac X et al (2020) Description of neurotoxicity in a series of patients treated with CAR T-cell therapy. Sci Rep 10:18997","journal-title":"Sci Rep"},{"key":"11595_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/CJI.0000000000000241","volume":"41","author":"H Shalabi","year":"2018","unstructured":"Shalabi H, Wolters PL, Martin S et al (2018) Systematic evaluation of neurotoxicity in children and young adults undergoing CD22 chimeric antigen receptor T-cell therapy. J Immunother 41:350\u2013358","journal-title":"J Immunother"},{"key":"11595_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1212\/WNL.0000000000201083","volume":"99","author":"R Ursu","year":"2022","unstructured":"Ursu R, Maillet D, Belin C et al (2022) Long-term neurologic safety in patients with B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy. Neurology 99:511\u2013515","journal-title":"Neurology"},{"key":"11595_CR22","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.3390\/cancers13194789","volume":"13","author":"B Casadei","year":"2021","unstructured":"Casadei B, Argnani L, Guadagnuolo S et al (2021) Real world evidence of CAR T-cell therapies for the treatment of relapsed\/refractory B-cell non-Hodgkin lymphoma: a monocentric experience. Cancers (Basel) 13:4789","journal-title":"Cancers (Basel)"},{"key":"11595_CR23","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting. J Clin Oncol 7:1630\u20131636","journal-title":"J Clin Oncol"},{"key":"11595_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","volume":"38","author":"LJ Hirsch","year":"2021","unstructured":"Hirsch LJ, Fong MWK, Leitinger M et al (2021) American clinical neurophysiology society\u2019s standardized critical care EEG terminology: 2021 version. J Clin Neurophysiol 38:1\u201329","journal-title":"J Clin Neurophysiol"},{"key":"11595_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol 149:351\u2013356","journal-title":"AJR Am J Roentgenol"},{"key":"11595_CR26","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"American Psychiatric Association DSM-5: diagnostic and statistical manual of mental disorders","author":"AP Association","year":"2013","unstructured":"Association AP (2013) American Psychiatric Association DSM-5: diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Washington","edition":"5"},{"key":"11595_CR27","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1007\/s00415-020-10237-3","volume":"268","author":"EC Tallantyre","year":"2021","unstructured":"Tallantyre EC, Evans NA, Parry-Jones J, Morgan MPG, Jones CH, Ingram W (2021) Neurological updates: neurological complications of CAR-T therapy. J Neurol 268:1544\u20131554","journal-title":"J Neurol"},{"key":"11595_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00415-021-10766-5","volume":"269","author":"U Pensato","year":"2022","unstructured":"Pensato U, Amore G, D\u2019Angelo R et al (2022) Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity. J Neurol 269:609\u2013615","journal-title":"J Neurol"},{"key":"11595_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neubiorev.2020.02.006","volume":"112","author":"H Arnts","year":"2020","unstructured":"Arnts H, van Erp WS, Lavrijsen JCM, van Gaal S, Groenewegen HJ, van den Munckhof P (2020) On the pathophysiology and treatment of akinetic mutism. Neurosci Biobehav Rev 112:270\u2013278","journal-title":"Neurosci Biobehav Rev"},{"key":"11595_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100272","volume":"15","author":"U Pensato","year":"2021","unstructured":"Pensato U, Muccioli L, Janigro D, Guarino M, Bisulli F, Cortelli P (2021) Akinetic mutism in COVID-19-related encephalopathy: a cytokine-mediated maladaptive sickness behavioral response? Brain Behav Immun Health 15:100272","journal-title":"Brain Behav Immun Health"},{"key":"11595_CR31","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","volume":"377","author":"SS Neelapu","year":"2017","unstructured":"Neelapu SS, Locke FL, Bartlett NL et al (2017) Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N Engl J Med 377:2531\u20132544","journal-title":"N Engl J Med"},{"key":"11595_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/00001503-199908000-00010","volume":"12","author":"EP Horn","year":"1999","unstructured":"Horn EP (1999) Postoperative shivering: aetiology and treatment. Curr Opin Anaesthesiol 12:449\u2013453","journal-title":"Curr Opin Anaesthesiol"},{"key":"11595_CR33","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S1473-3099(05)70270-X","volume":"5","author":"R Eccles","year":"2005","unstructured":"Eccles R (2005) Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 5:718\u2013725","journal-title":"Lancet Infect Dis"},{"key":"11595_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/neuonc\/noab174","volume":"24","author":"I Beuchat","year":"2022","unstructured":"Beuchat I, Danish HH, Rubin DB et al (2022) EEG findings in CAR T-cell-associated neurotoxicity: Clinical and radiological correlations. Neuro Oncol 24:313\u2013325","journal-title":"Neuro Oncol"},{"key":"11595_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cns.13569","volume":"27","author":"X Huang","year":"2020","unstructured":"Huang X, Hussain B, Chang J (2020) Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neurosci Ther 27:36\u201347","journal-title":"CNS Neurosci Ther"},{"key":"11595_CR36","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/acn3.51348","volume":"8","author":"U Pensato","year":"2021","unstructured":"Pensato U, Muccioli L, Cani I et al (2021) Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy. Ann Clin Transl Neurol 8:968\u2013979","journal-title":"Ann Clin Transl Neurol"},{"key":"11595_CR37","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH (2020) Cytokine storm. N Engl J Med 383:2255\u20132273","journal-title":"N Engl J Med"},{"key":"11595_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","volume":"22","author":"EC Morris","year":"2022","unstructured":"Morris EC, Neelapu SS, Giavridis T, Sadelain M (2022) Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nat Rev Immunol 22:85\u201396","journal-title":"Nat Rev Immunol"},{"key":"11595_CR39","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41409-019-0602-5","volume":"54","author":"CK Chou","year":"2019","unstructured":"Chou CK, Turtle CJ (2019) Insight into mechanisms associated with cytokine release syndrome and neurotoxicity after CD19 CAR-T cell immunotherapy. Bone Marrow Transplant 54:780\u2013784","journal-title":"Bone Marrow Transplant"},{"key":"11595_CR40","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s40263-018-0582-9","volume":"32","author":"J Gust","year":"2018","unstructured":"Gust J, Taraseviciute A, Turtle CJ (2018) Neurotoxicity associated with CD19-targeted CAR-T cell therapies. CNS Drugs 32:1091\u20131101","journal-title":"CNS Drugs"},{"key":"11595_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100307","volume":"16","author":"EO Sjostrom","year":"2021","unstructured":"Sjostrom EO, Culot M, Leickt L et al (2021) Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier. Brain Behav Immun Health 16:100307","journal-title":"Brain Behav Immun Health"},{"key":"11595_CR42","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1182\/bloodadvances.2020002328","volume":"4","author":"P Strati","year":"2020","unstructured":"Strati P, Ahmed S, Kebriaei P et al (2020) Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma. Blood Adv 4:3123\u20133127","journal-title":"Blood Adv"},{"key":"11595_CR43","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1038\/s41591-021-01564-7","volume":"27","author":"O Van Oekelen","year":"2021","unstructured":"Van Oekelen O, Aleman A, Upadhyaya B et al (2021) Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy. Nat Med 27:2099\u20132103","journal-title":"Nat Med"},{"key":"11595_CR44","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2174\/1570159X18666200221113842","volume":"18","author":"A Das","year":"2020","unstructured":"Das A, Ranadive N, Kinra M, Nampoothiri M, Arora D, Mudgal J (2020) An overview on chemotherapy-induced cognitive impairment and potential role of antidepressants. Curr Neuropharmacol 18:838\u2013851","journal-title":"Curr Neuropharmacol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11595-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11595-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11595-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T08:12:44Z","timestamp":1702023164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11595-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["11595"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11595-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"21 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All investigations were carried out according to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Written informed consent was collected from the patient for the inclusion of deidentified clinical data in a scientific publication, in accordance with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agreed with this final version.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}